Fintel reports that on March 21, 2025, William Blair downgraded their outlook for Valmont Industries (NYSE:VMI) from ...

Equities research analysts at William Blair issued their Q1 2026 earnings per share estimates for shares of MiNK Therapeutics ...

NVIDIA (NASDAQ:NVDA – Get Free Report)‘s stock had its “outperform” rating reaffirmed by William Blair in a report released ...

Fintel reports that on March 20, 2025, William Blair downgraded their outlook for Beacon Roofing Supply (NasdaqGS:BECN) from ...

Emerging markets present a landscape of opportunity for equity investors despite macroeconomic headwinds. Click to read.

We recently published a list of Top 9 AI News Updates Investors Probably Missed. In this article, we are going to take a look ...

As Klarna wins installment lending for the retail giant's OnePay app, rival Affirm seeks to downplay the loss.

Novartis' Fabhalta has become the first treatment approved by the FDA for the ultra-rare kidney disease C3G. But analysts ...

We recently compiled a list of the 10 AI Stocks Investors Are Watching Closely Right Now. In this article, we are going to ...

The note emphasized that Palantir shares declined 10% following a 4% selloff in the Nasdaq, and if the broader market ...

Palantir (PLTR) was upgraded to Market Perform from Underperform by William Blair, following the recent share price decline by the data analysis and artificial intelligence software firm.

William Blair downgraded Udemy (UDMY) to Market Perform from Outperform after the company announced the appointment of Hugo Sarrazin as ...